4.445
price down icon8.07%   -0.39
after-market After Hours: 4.48 0.035 +0.79%
loading

Humacyte Inc Stock (HUMA) Forecast

The Humacyte Inc (HUMA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.385, representing a -91.34% decrease from the current price of $4.445. The highest analyst price target is $0.5687, and the lowest is $0.2012.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HUMA Price Target
Average 1.6508 (-62.86% Downside)
loading

Is Humacyte Inc (HUMA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 35.82 Neutral
STOCH(9,6) 23.86 Neutral
STOCHRSI(14) 47.90 Neutral
MACD(12,26) -0.1682 Sell
ADX(14) 11.35 Neutral
William %R -90.00 Buy
CCI(14) -213.24 Sell
Buy: 1 Sell: 2 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
5.203
Sell
5.0707
Sell
MA20
5.302
Sell
5.2225
Sell
MA50
5.4013
Sell
5.4949
Sell
MA100
6.148
Sell
5.6474
Sell
MA200
5.3851
Sell
5.2881
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, HUMA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on HUMA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 35.82 indicates that HUMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 23.86 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 47.9 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 11.35 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -213.24 indicates that HUMA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term HUMA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Humacyte Inc financial reports and earnings history, Humacyte Inc (HUMA) stock could reach $4.3258 by 2030, $35.15 by 2040 and $44.87 by 2050. See the projected annual prices until 2050 of the Humacyte Inc stock below:

  • Humacyte Inc (HUMA) is expected to reach an average price of $17.66 in 2035, with a high prediction of $17.91 and a low estimate of $17.93. This indicates an $297.28% rise from the last recorded price of $4.445.
  • Humacyte Inc (HUMA) stock is projected to chart a bullish course in 2040, with an average price target of $34.72, representing an $681.12% surge from its current level. The forecast ranges from a conservative $34.87 to a sky-high $35.15.
  • Our analysts predict Humacyte Inc (HUMA) to jump 380.07% by 2045, soaring from $21.56 to an average price of $21.34, potentially reaching $21.92. While $21.56 is the low estimate, the potential upside is significant.
  • Humacyte Inc (HUMA) stock is expected to climb by 2050, reaching an average of $44.20, a $894.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $44.87 and $44.38, respectively, highlighting the market's uncertainty.

Humacyte Inc Stock (HUMA) Year by Year Forecast

Humacyte Inc Stock (HUMA) Price Forecast for 2024

Our forecast for HUMA stock price in 2024 now indicates an average price target of $3.2472 with a high forecast of $6.35 and a low forecast of $0.1443. The average prediction reflects an decrease of -26.95% from the last recorded price of $4.445.
Month Average Low High Change from today's price
December, 2024 $0.3875 $0.2012 $0.5687 -91.28%

Humacyte Inc Stock (HUMA) Price Forecast for 2025

Humacyte Inc Stock (HUMA) is expected to reach an average price of $1.6508 in 2025, with a high prediction of $3.288 and a low estimate of $0.0136. This indicates an -62.86% fall from the last recorded price of $4.445.
Month Average Low High Change from today's price
January, 2025 $1.499 $0.0136 $1.0698 -66.28%
February, 2025 $0.6141 $1.2941 $1.6053 -86.18%
March, 2025 $3.3893 $2.6304 $3.1146 -23.75%
April, 2025 $2.9507 $3.1207 $3.2456 -33.62%
May, 2025 $2.1059 $1.9895 $2.817 -52.62%
June, 2025 $2.2111 $2.2548 $2.0022 -50.26%
July, 2025 $2.6525 $2.7573 $2.6862 -40.33%
August, 2025 $2.6477 $2.5751 $2.3601 -40.44%
September, 2025 $2.5728 $2.6928 $2.5539 -42.12%
October, 2025 $3.3043 $2.8741 $3.288 -25.66%
November, 2025 $2.7894 $2.8594 $2.9605 -37.25%
December, 2025 $2.1909 $2.3709 $2.1183 -50.71%

Humacyte Inc Stock (HUMA) Price Forecast for 2026

The predicted value for Humacyte Inc (HUMA) in 2026 is set at an average of $1.2521. Estimates vary from a peak of $2.1147 to a trough of $0.3895, indicating an -71.83% surge from the present price of $4.445.
Month Average Low High Change from today's price
January, 2026 $2.206 $2.2771 $2.1147 -50.37%
February, 2026 $1.6712 $1.7787 $1.8186 -62.40%
March, 2026 $0.7063 $1.0563 $1.5075 -84.11%
April, 2026 $1.4578 $1.1815 $1.0997 -67.20%
May, 2026 $1.5129 $1.7929 $1.6866 -65.96%
June, 2026 $1.3081 $1.3381 $1.4205 -70.57%
July, 2026 $0.1995 $0.3895 $0.8744 -95.51%
August, 2026 $1.1747 $0.5558 $1.0847 -73.57%
September, 2026 $1.8161 $1.3889 $1.7461 -59.14%
October, 2026 $1.2113 $1.3713 $1.5024 -72.75%
November, 2026 $0.5764 $0.9964 $0.9976 -87.03%
December, 2026 $0.8279 $0.814 $0.8279 -81.38%

Humacyte Inc Stock (HUMA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Humacyte Inc (HUMA) is $4.7243, with a high forecast of $9.4241 and a low forecast of $0.0245. This indicates an +6.28% increase from the last price of $4.445.
Month Average Low High Change from today's price
January, 2027 $0.267 $0.1967 $0.3942 -93.99%
February, 2027 $0.0118 $0.2382 $1.5624 -99.73%
March, 2027 $0.0196 $0.0245 $0.5329 -99.56%
April, 2027 $0.9952 $0.1322 $1.2852 -77.61%
May, 2027 $5.1352 $1.0389 $4.2752 +15.53%
June, 2027 $5.068 $6.0477 $5.9855 +14.02%
July, 2027 $4.7284 $5.5031 $4.8506 +6.37%
August, 2027 $7.5287 $5.4402 $6.1587 +69.37%
September, 2027 $10.30 $8.1412 $9.2616 +131.76%
October, 2027 $9.3119 $9.3519 $9.4241 +109.49%
November, 2027 $8.7222 $8.9429 $8.7944 +96.22%
December, 2027 $7.4251 $7.2725 $7.8948 +67.04%

Humacyte Inc Stock (HUMA) Price Forecast for 2028

In 2028, Humacyte Inc (HUMA) is projected to reach an average price of $8.367, with a high projection of $9.8112 and a low estimate of $6.9228. This indicates an +88.23% rise from the last price of $4.445.
Month Average Low High Change from today's price
January, 2028 $7.5254 $6.9228 $6.5277 +69.30%
February, 2028 $8.1057 $8.2557 $8.4405 +82.36%
March, 2028 $9.9886 $8.0283 $9.7139 +124.72%
April, 2028 $9.4839 $9.6089 $9.8112 +113.36%
May, 2028 $8.4018 $8.3191 $9.2915 +89.02%
June, 2028 $8.3721 $8.4495 $8.2644 +88.35%
July, 2028 $8.9024 $8.8847 $8.7248 +100.28%
August, 2028 $8.5053 $8.5001 $8.585 +91.35%
September, 2028 $8.2956 $8.4156 $8.3779 +86.63%
October, 2028 $9.0659 $8.5632 $8.8759 +103.96%
November, 2028 $8.2088 $8.2788 $8.7885 +84.68%
December, 2028 $7.6591 $7.6991 $7.4514 +72.31%

Humacyte Inc Stock (HUMA) Price Forecast for 2029

The 2029 price forecast for Humacyte Inc Stock (HUMA) is $5.8549 on average, with a high prediction of $7.2967 and a low estimate of $4.413. This represents an +31.72% increase from the previous price of $4.445.
Month Average Low High Change from today's price
January, 2029 $7.322 $7.4943 $7.2967 +64.72%
February, 2029 $6.6523 $6.7598 $6.8672 +49.66%
March, 2029 $5.5526 $5.9026 $6.4549 +24.92%
April, 2029 $5.093 $5.893 $5.8449 +14.58%
May, 2029 $6.0558 $6.2955 $6.2633 +36.24%
June, 2029 $5.7162 $5.7462 $5.896 +28.60%
July, 2029 $4.7165 $4.927 $5.2487 +6.11%
August, 2029 $5.2794 $4.629 $5.1894 +18.77%
September, 2029 $5.9297 $5.4598 $5.6547 +33.40%
October, 2029 $5.0126 $5.1726 $5.6822 +12.77%
November, 2029 $4.2429 $4.6629 $4.7651 -4.55%
December, 2029 $4.4132 $4.413 $4.1632 -0.72%

Humacyte Inc Stock (HUMA) Price Forecast for 2030

Humacyte Inc Stock (HUMA) is expected to reach an average price of $9.3592 in 2030, with a high forecast of $16.87 and a low forecast of $1.8522. This signifies an +110.56% surge from the last price of $4.445.
Month Average Low High Change from today's price
January, 2030 $3.0961 $3.5935 $4.3258 -30.35%
February, 2030 $3.2164 $2.2738 $2.9464 -27.64%
March, 2030 $3.0767 $2.9941 $2.9115 -30.78%
April, 2030 $1.927 $2.617 $2.8869 -56.65%
May, 2030 $13.22 $1.8522 $12.36 +197.36%
June, 2030 $14.79 $14.10 $13.93 +232.81%
July, 2030 $12.51 $13.35 $12.73 +181.38%
August, 2030 $15.17 $13.15 $13.80 +241.35%
September, 2030 $17.31 $15.75 $16.75 +289.39%
October, 2030 $16.65 $16.69 $16.87 +274.64%
November, 2030 $15.93 $16.22 $16.10 +258.34%
December, 2030 $14.06 $14.34 $15.07 +216.39%
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Cap:     |  Volume (24h):